| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $100.6M | +3.6% |
| R&D Expense | $185.9M | -3.2% |
| SG&A Expense | $59.6M | +5.2% |
| Operating Income | -$145.0M | +4.4% |
| Pre-tax Income | -$118.9M | +5.0% |
| Income Tax | $128K | -97.5% |
| Net Income | -$119.0M | +8.7% |
| EPS (Basic) | -$1.23 | +21.2% |
| EPS (Diluted) | -$1.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.0M | -55.7% |
| Short-term Investments | $380.4M | -19.8% |
| Current Assets | $424.8M | -24.9% |
| Total Assets | $468.3M | -24.7% |
| Current Liabilities | $125.1M | -29.7% |
| Long-term Debt | $10.0M | — |
| Total Liabilities | $341.5M | -30.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$229.9M | -24.8% |
| Capital Expenditures | $1.3M | -47.3% |
| Investing Cash Flow | $107.1M | +5.1% |
| Financing Cash Flow | $81.5M | +3097.6% |
| Free Cash Flow | -$231.2M | -23.9% |
| +21.2% |
| Stockholders' Equity |
| $126.8M |
| -5.5% |